Retirides

Quick links to important sections

Retirides

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Retirides

Property Description
Active Ingredient Tretinoin (all-trans-retinoic acid)
Form Cream or emulsion
Pharmacological Class Retinoid (Vitamin A analogue)
Route of Administration Topical (dermal)
Origin Synthetic compound

What Type of Medicine is Retirides? (Identity and Classification)

Retirides is a specialized topical formulation containing the active ingredient, Tretinoin, which is classified as a first-generation Retinoid. This prescription-only medicine (POM) is fundamentally a synthetic compound derived from Vitamin A, known chemically as all-trans-retinoic acid. The Tretinoin identity is recognized for its influence on skin cell life cycles.

The brand Retirides itself is distinguished as a Tretinoin preparation utilized in European dermatological therapy. Its presence confirms its role as a compound that fundamentally acts to reorganize skin structure, distinguishing it from cosmetic Vitamin A derivatives.


Retirides Composition and Dosage Form (Substance and Delivery)

The Retirides preparation is a single-entity product, utilizing Tretinoin as the sole active ingredient within a stable cream or emulsion base, which constitutes the final dosage form. This Topical route of administration is a critical factor, specifically chosen to maximize the concentration of the compound at the skin surface while ensuring minimal systemic absorption.

This specific formulation is optimized for dermal delivery, ensuring the medication penetrates the epidermis effectively. Tretinoin is utilized as an ingredient in dermatological preparations intended for direct application to the skin, emphasizing its localized therapeutic profile.


General Purpose: What Does Tretinoin Fundamentally Do? (General Benefit)

The general function of Tretinoin is to effect substantial skin renewal through its primary physiological actions: keratolysis and comedolysis. It achieves this by regulating cell differentiation and accelerating the cell turnover rate.

By promoting the normalized and organized shedding of the outer skin layer (keratinization), Tretinoin helps prevent blockages. This capability to regulate epithelial cells forms the basis for its general therapeutic application in conditions that benefit from accelerated skin shedding and improved structural integrity.

Regulatory References

  1. NIH/StatPearls Tretinoin Monograph

What side effects are possible with Retirides?

Possible side effects and safety information

The official safety information for Tretinoin (the active ingredient in Retirides) is defined primarily by its localized effects on the skin and specific population constraints. Adverse reactions are classified according to regulatory standards and primarily fall under Skin and Subcutaneous Tissue Disorders.

Documented Adverse Reactions and Frequency

Localized skin reactions such as erythema (redness), dryness, peeling, pruritus (itching), and a burning sensation are officially classified as Very Common or Common based on regulatory documents. These manifestations often reflect the medicine's activity on the skin and are generally most noticeable during the initial weeks of treatment.

Classification Manifestation (Examples)
Most Common Skin irritation, peeling/scaling, dryness, burning, erythema
Less Frequent Swelling (edema), blistering, crusting, hyper-/hypopigmentation

Safety Considerations and Restrictions

Safety documents highlight that Tretinoin can cause a severe reaction on eczematous skin and must be used with caution in this condition. A major non-dosing related restriction is the heightened risk of photosensitivity; minimization or avoidance of UV light exposure (sunlight and sunlamps) is required during use. The official safety profile also notes that an apparent worsening of the condition being treated, such as an acne flare-up, may be observed during the first two to three weeks of therapy, reflecting a time-related pattern documented in clinical use.

Population Constraint: Tretinoin is officially contraindicated in women who are pregnant or planning to become pregnant due to the class-specific risk of harm to the fetus.

Overdose and Emergency Response

The official regulatory profile for topical Tretinoin overdose recognizes two distinct exposure scenarios.

Overdose Scope

Over-application is the most common form of overdose, primarily affecting the Dermal System. This results in an excessive local reaction, including marked redness (erythema), excessive peeling, and increased discomfort at the application site. Applying larger amounts than directed does not yield faster or better results, but significantly increases the risk of this local irritation. The official regulatory documentation indicates that minimal systemic absorption is expected, which suggests that severe systemic toxicity is not typically documented following dermal overdose.

Emergency-Response and Management

A critical emergency scenario is Accidental Oral Ingestion of the cream. In this case, the drug may lead to potential systemic effects that can be similar to those associated with excessive oral intake of Vitamin A, such as headache, flushing, and stomach pain. Immediate medical attention is required for accidental ingestion; users must call a poison control center right away. If the person has collapsed or is not breathing, emergency services must be called. Management is universally documented as being symptomatic and supportive, as no specific antidote is known for Tretinoin. If local irritation from over-application is warranted, regulators advise reducing the frequency or discontinuing use temporarily.

Therapeutic Uses of Retirides

What Retirides Treats: Main Uses and Benefits

The primary role of Retirides cream is to provide supportive symptomatic management for specific dermatological conditions. The medication is characterized by its use across two core therapeutic domains: the treatment of Acne Vulgaris and the adjunctive management of photoaging (sun-damaged skin).

It is relevant in clinical settings marked by increased discomfort or tension, and the medication is commonly used to help with symptomatic manifestations such as blackheads, whiteheads, fine facial wrinkles, and mottled hyperpigmentation. This application provides support that helps ease the overall symptom burden in situations involving recurrent or episodic manifestations.


Therapeutic Domains and Patient Benefit

This topical treatment may assist with managing the visible impact of chronic sun damage to the facial skin. It is applied when appropriate for conditions presenting with symptoms that may intensify temporarily, and helps improve day-to-day comfort by helping to ease the appearance of these signs of aging. It is considered relevant across therapeutic areas involving heightened symptom expression and is commonly used to help address discoloration.


Quick Fact: Relief for Textural Irregularities The medication is commonly used to help with tactile roughness and uneven skin texture associated with photoaging, providing supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility profile for Retirides (topical Tretinoin) is strictly defined by official regulatory documentation based on population groups, physiological states, and pre-existing conditions.

Eligibility Scope

Classification Status and Population Group (As Stated in Regulatory Labels)
Populations for whom use is contraindicated Women who are pregnant or planning a pregnancy (absolute prohibition). Patients with a known hypersensitivity or allergy to Tretinoin or any component of the formulation.
Conditions in which use must be avoided Skin with sunburn (until fully recovered). Skin affected by eczema or areas with open cuts or abrasions (use must be avoided due to severe irritation risk).
Age-related eligibility rules Safety and effectiveness have not been established for many Tretinoin formulations in children under 12 years of age. Use in older adults (50 years and older) for certain indications may require specific dose determination.
Pregnancy and lactation eligibility status Contraindicated in pregnancy. Not recommended for nursing mothers due to unknown excretion into human milk.
Eligibility-related restrictions Individuals with occupational sun exposure or inherent photosensitivity must use the product with utmost caution and must adhere strictly to sun protection measures.

Connection to the overall eligibility profile: The regulatory profile explicitly defines who can and cannot use the medicine by setting absolute prohibitions based on reproductive status and prohibiting use on specific irritated or damaged skin. The classifications of Contraindicated, Not Recommended, and Use Not Established strictly govern the population eligibility for this medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details the documented interaction profile for topical Tretinoin, which is primarily focused on local dermal effects rather than systemic drug-drug interactions, consistent with its minimal systemic absorption.

Documented Interaction Categories

Interaction Type Interacting Substances/Classes
Pharmacodynamic Interaction Other topical desquamative or irritating agents.
Photosensitivity Risk Systemic photosensitizing agents (e.g., tetracyclines, thiazides).

Co-administration with other topical medicines containing peeling, drying, or irritating agents, such as benzoyl peroxide, salicylic acid, or sulfur, results in an officially documented additive pharmacodynamic effect, leading to increased local dryness or irritation. To mitigate this effect, mandatory timing separation is required for the application of Tretinoin and such topical irritants.

The use of topical Tretinoin alongside systemic medications known to induce photosensitivity, including tetracyclines or thiazides, carries a documented risk of increased photosensitivity to UV light. Regulatory labels advise caution regarding sun exposure under these circumstances.

Official regulatory documentation does not state clinically relevant interactions mediated by CYP enzymes or drug transporters, nor does it list formal systemic contraindications for the topical formulation.

Mechanism of Action

Retirides Mechanism of Action

Retirides (tretinoin) exerts its action by functioning as an agonist for the Retinoic Acid Receptors (RARs), primarily the RAR-alpha, RAR-beta, and RAR-gamma subtypes located in the cell nucleus. Binding to these receptors enables heterodimerization with Retinoid X Receptors (RXRs), leading to the modulation of gene transcription by binding to specific DNA sequences (RAREs).

This transcriptional regulation results in accelerated keratinocyte proliferation and normalization of their differentiation process. The mechanism modulates the abnormal cellular cohesion and desquamation within the hair follicle, affecting the process that leads to pore obstruction. In the dermis, tretinoin simultaneously stimulates the synthesis of procollagen (Type I and III) and down-regulates the activity of Matrix Metalloproteinases (MMPs), particularly collagenases. This dual-action pathway results in the remodeling and thickening of the dermis and influences the structural support characteristics of the skin. Furthermore, tretinoin engages mechanisms that down-regulate the expression of certain inflammatory mediators, thereby modulating localized inflammatory signaling within the tissue.

Dosage and Administration Information

How to Use Retirides — Administration Guidelines

This section describes the standard administration parameters for Tretinoin topical formulations, such as Retirides.

Administration Scope

Feature Guideline
Route of Administration Strictly Topical (dermal) application only. The product is not intended for oral, ophthalmic, or intravaginal use.
Dosing Schedule The standard regimen is application once daily, typically in the evening or before retiring. The dose is a thin layer applied to the entire affected area.
Application Amount A pea-sized amount is considered sufficient for the entire face when treating fine wrinkles. If the applied cream remains visible, too much product was used.
Preparation Requirements Application must occur only after cleansing and drying the skin. It is standard to wait 20 to 30 minutes after washing to ensure the skin is completely dry.
Age-Group Rules Use for the acne indication is generally indicated for patients 12 years of age and older.

Treatment Protocol and Duration

Classification Description
Frequency Pattern Once daily. The application frequency may be temporarily reduced if local irritation is observed.
Course Duration For conditions like photoaging, the established duration of continuous therapy is up to 48 to 52 weeks. Improvement for acne may require seven or more weeks of consistent use.
Use-Context Constraints Tretinoin is used as an adjunct to a comprehensive sun avoidance program, requiring the concurrent use of appropriate sun protection.

Connection to the Overall Use Protocol

The use of Tretinoin topical involves a once-daily, evening application to a prepared, fully dry skin surface. This protocol defines the precise amount (a thin layer) and sets the expectation for the treatment's long-term duration, clarifying the standardized application parameters.

Recent Clinical Evidence

Research evidence / Overview of studies for Retirides (Tretinoin)


Evidence for Use in Acne Vulgaris

Research examining Tretinoin for acne vulgaris primarily uses numerous short-term Randomized Controlled Trials (RCTs). These studies were used to explore how symptoms change over periods of 11 to 12 weeks. Researchers applied Tretinoin against a non-medicated cream (vehicle) in populations of adults and adolescents (aged 12 and older) presenting with mild-to-moderate and moderate-to-severe acne. The core outcomes monitored were the precise measurement of inflammatory and non-inflammatory lesion counts and the proportion of subjects achieving a defined clinical success rating.

Findings describe patterns observed in these studies, where studies reported measurements of lower lesion counts in the Tretinoin groups compared to the vehicle groups. The research for this use is supported by evidence compiled over decades; however, certain areas remain uncertain, including long-term outcomes beyond the initial controlled trial period and the need for new high-quality trials to facilitate comparisons with other topical agents.


Evidence for Use in Photoaging (Sun-Damaged Skin)

Research evaluating Tretinoin in the context of symptoms associated with sun-damaged facial skin is supported by long-term Randomized Controlled Trials (RCTs), with observation periods extending up to 24 months. These studies were applied in research contexts involving fluctuating symptoms, such as fine facial wrinkles, mottled hyperpigmentation (discoloration), and tactile roughness (uneven texture).

Studies reported observations of lower clinical grading scores for wrinkles, skin texture, and hyperpigmentation in the Tretinoin treatment groups compared to the vehicle groups. Findings were mixed across studies, which scientific reviews indicate was associated with the use of different formulations (such as cream versus gel) and varying outcome measurement parameters over the research history.


What is Still Uncertain in the Research

Research contributes to the broader evidence landscape, but some areas of uncertainty remain. The evidence quality varies across studies, particularly for older foundational trials. Follow-up durations were limited for some acne studies, and long-term effects regarding the continuity of observed findings are not fully established. Furthermore, comparative evidence is lacking for Tretinoin when compared directly against other topical treatments in large, long-term studies.

Key Studies & References

  1. Tretinoin Topical Monograph - MedlinePlus Drug Information
  2. Tretinoin: A Comprehensive Review on Evidence and Clinical Use for Acne and Photoaging
  3. Topical Tretinoin for Acne Vulgaris: A Systematic Review of Clinical Efficacy

Frequently Asked Questions (FAQ)

Common questions about Retirides (FAQ)


Q: What does 'purging' mean when people talk about using Retirides?

Regulatory information notes that an apparent worsening of the treated condition, such as an acne flare-up, may occur during the first few weeks of therapy. This initial period is often referred to by users as 'purging.' Official documents indicate this is an expected time-related pattern and is not typically a reason to discontinue the medication based on official guidance.


Q: Are there any long-term side effects associated with Retirides use?

Official regulatory summaries state that the safety and effectiveness of the medication for chronic conditions like photoaging have not been formally established for continuous use beyond 48 weeks. For the established duration of use, common adverse effects are expected. These include localized skin reactions like redness, dryness, and scaling, which are expected to decrease in severity during the course of therapy.


Q: Is it safe to use Retirides with other acidic skincare ingredients?

Official documents caution against the concurrent use of Retirides with other topical products that have peeling, drying, or irritating properties. This includes ingredients such as sulfur, resorcinol, and salicylic acid. Combining these agents can lead to a severe additive effect, potentially causing excessive irritation or dryness.


Q: Are there different names for the same drug ingredient found in Retirides?

The active ingredient in Retirides is Tretinoin. According to official drug dictionaries, the chemical name for this compound is all-trans-retinoic acid, often abbreviated as ATRA. This is the official scientific term for the drug substance.


Q: Does skin peeling indicate that Retirides is working?

Peeling is classified as a very common local adverse reaction that is expected as part of the initial response to the medication. Official information states that this peeling reflects the medicine's activity on the skin. However, if peeling becomes excessive, official guidance may advise adjustment to the amount or frequency of application.


Q: What kind of sun protection is recommended when using Retirides?

Regulatory patient information strongly advises that the medication be used alongside a comprehensive sun protection plan due to the risk of photosensitivity. Regulatory documentation advises the concurrent use of a broad-spectrum sunscreen with an appropriate Sun Protection Factor (SPF). Additionally, official guidelines recommend wearing sun-protective clothing and minimizing overall sun exposure.


Q: What is the role of the vehicle cream or base in Retirides formulations?

The vehicle, such as the cream or emulsion base, serves as the stable carrier for the active ingredient, Tretinoin. It is designed for the specific topical route of administration, which is intended to facilitate the medication’s localized action on the skin surface. The base ingredients are listed in the official documents primarily for patient safety.


Q: Does Retirides have a different purpose depending on the cream strength?

Official regulatory indications state that different available strengths of the cream are generally approved for the same primary topical treatments, such as acne vulgaris or the symptoms of sun-damaged skin. The choice of strength is typically related to the patient's skin tolerance and reaction, not a difference in the fundamental purpose of the drug.


Q: Are there any dietary restrictions or supplements that interact with Retirides?

Official information for Tretinoin cautions against the co-administration of therapeutic Vitamin A supplements (doses typically greater than 10,000 units per day). This caution is due to the potential for excessive Vitamin A effects since Retirides itself is a Vitamin A derivative. Official information does not widely report restrictions for general food or beverage consumption when using the topical form.


Q: Is Retirides suitable for people with sensitive skin?

Official product information notes that individuals with inherently sensitive skin are at a higher risk of experiencing severe local irritation. This may manifest as excessive redness, swelling, or blistering. If such severe reactions occur, official guidance indicates that adjustment to the frequency of application or temporary discontinuation may be advised.


Q: Does Retirides stop working after a certain period of use?

Official clinical studies and regulatory documents emphasize that the medicine requires continued, consistent use to maintain its observed effects. The optimal benefits for conditions like acne may take more than seven weeks of therapy to be seen. Regulatory information does not describe a mechanism by which the skin develops a tolerance or the drug stops working over time.


Q: Is Retirides considered a steroid?

According to official drug classification, Retirides is a Retinoid. It is classified as a synthetic compound derived from Vitamin A, known chemically as all-trans-retinoic acid. It is not considered a steroid compound, which belongs to a different pharmacological class of medicines.


Q: Can Retirides be used on other body areas besides the face?

Regulatory documents state that the application involves a thin layer to the designated affected area of skin. For approved uses like acne vulgaris, this instruction may include body areas other than the face, such as the back or chest, where the condition appears.


Q: What kind of moisturizers are generally considered safe to use with Retirides?

Patient counseling guides refer to water-based creams or lotions as supportive products that may help mitigate common dryness and irritation associated with the use of the medicine. The recommendation is to avoid products that might be excessively drying, abrasive, or irritating.


Q: Does the concentration of Retirides affect the likelihood of side effects?

Official warnings state that using a higher concentration of the product or applying an amount greater than the recommended thin layer may increase the likelihood and severity of adverse effects. This includes intensifying common reactions such as peeling, redness, and skin inflammation.


Q: Is Retirides used to treat rosacea?

According to regulatory documents, the approved uses for the active ingredient in Retirides are limited to the treatment of acne vulgaris and, for specific formulations, the symptoms of photoaging. Rosacea is not listed in the official indications for this medicine.


Q: Can Retirides cause permanent skin changes?

Official literature advises that Retirides does not completely eliminate existing fine wrinkles or reverse the entire photoaging process. While the medicine facilitates dermal remodeling, temporary skin changes, such as hyperpigmentation or hypopigmentation (darker or lighter skin patches), have been reported in safety data.


Q: What is the risk described in official sources if Retirides is accidentally ingested?

The official patient instructions clearly warn that the medication is for topical use only and may cause harm if swallowed. If accidental ingestion occurs, official regulatory guidance advises seeking immediate professional medical assistance or contacting a poison control center.


Q: Are there official studies on the use of Retirides in male patients?

Official regulatory trial registries confirm that clinical studies used to establish the efficacy and safety of Tretinoin for its approved indications included both male and female adult and adolescent participants in their patient population criteria.


Q: What kind of research is currently being done on tretinoin?

Government-run clinical trial registries often list official studies that are currently active or recruiting participants for various uses of the active ingredient Tretinoin. This allows for public tracking of ongoing research themes and trials sponsored by authoritative bodies.


Q: Are there specific cosmetics or perfumes mentioned as interacting with Retirides?

Official warnings advise avoiding certain cosmetics, soaps, and hair products that have a strong drying effect or may cause skin irritation. Additionally, products containing ingredients such as spices or limes, which can be found in some perfumes or cosmetic items, are noted as potential irritants to be avoided.


Q: What is the official recommendation regarding hair removal methods while using Retirides?

Regulatory warnings caution against the use of chemical depilatories, hair removers, or waxing on the skin being treated with Retirides. These methods are advised against in regulatory warnings because the medication increases the risk of causing severe irritation, peeling, or injury to the skin surface.

How should Retirides be stored and disposed of?

Storage and Disposal Requirements for Retirides (Tretinoin Cream)

The official storage conditions for Retirides cream mandate maintaining its stability within Controlled Room Temperature, typically 20^circC to 25^circC (68^circF to 77^circF). It is explicitly required to Protect from freezing and also to avoid exposure to excessive heat and direct light, as these conditions can compromise the product’s integrity.

Container and Safety

The medication must be kept in its original container and the cap must remain tightly closed to prevent contamination and maintain efficacy. Furthermore, official labeling requires the medication to be stored out of the reach of children. The Tretinoin gel formulation includes a specific warning to avoid fire or smoking during use, highlighting its flammability.

Disposal Mandates

Outdated or unused medicine must be discarded. Disposal of any remaining product should be conducted in accordance with local regulatory requirements after consultation with a pharmacist.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Retirides found in:

A-Z Index: